United States · 
Who invested in Psivant Therapeutics?
Psivant Therapeutics's investors include Samsara BioCapital.
United States · Series A startup
Who invested in Psivant Therapeutics
Funding summaryUpdated 26 Oct 2026
$48Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $48MDec 2025
- Investors
- 1
The rounds
- Dec 2025
Founders and team
From Psivant Therapeutics's own website: 5 on the team.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Psivant Therapeutics
How much has Psivant Therapeutics raised?
Psivant Therapeutics has raised $48M across 1 round since 2025.
When did Psivant Therapeutics last raise?
Psivant Therapeutics's most recent round was a Series A of $48M in Dec 2025.
What was Psivant Therapeutics's biggest round?
Its most recent round, $48M in Dec 2025, is also its largest on record.
Who backed Psivant Therapeutics first?
Psivant Therapeutics's first round on record, in Dec 2025, was backed by Samsara BioCapital.
What stage is Psivant Therapeutics at?
Psivant Therapeutics's latest named round is a Series A, in Dec 2025.
Where is Psivant Therapeutics based?
Psivant Therapeutics is based in the United States.
Companies like Psivant Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.